A Phase II, single arm, multicenter trial to determine t

Project: Research project

Project Details

Description

A Phase II, single arm, multicenter trial to determine the efficacy and safety of CTL019 in pediatrics patients with relapsed and refractory B-cell acute lymphoblastic leukemia
StatusActive
Effective start/end date3/2/1511/1/22

Funding

  • NOVARTIS PHARMACEUTICALS CORPORATION

Fingerprint

Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.